drugset
drugset / Trial / NCT03472534

A 21 Day Irritation Study in Healthy Volunteers With Diacerein 1% Ointment

NCT03472534 ↗

Phase 1 Completed 46 enrolled Castle Creek Pharmaceuticals, LLC TKL Research, Inc. · collab
NaSingle-groupOpen-labelOther

Summary

Single center, randomized, controlled, evaluator blinded, within-subject study to evaluate the irritation potential of diacerein1% ointment on normal skin of healthy volunteers, using a cumulative irritancy patch test (CIPT) procedure.

Timeline

Start
2018-01-09
Primary completion
2018-01-30
Completion
2018-01-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Diacerein Small molecule 0.2 ml Topical
Subject Diacerein Small molecule 1 % Topical

Indications

No indication recorded.